239 related articles for article (PubMed ID: 9508210)
1. Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review.
Bloomfield DJ
J Clin Oncol; 1998 Mar; 16(3):1218-25. PubMed ID: 9508210
[TBL] [Abstract][Full Text] [Related]
2. [Bisphosphonates and bone metastases].
Lortholary A; Jadaud E; Berthaud P
Bull Cancer; 1999 Sep; 86(9):732-8. PubMed ID: 10519966
[TBL] [Abstract][Full Text] [Related]
3. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD
J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035
[TBL] [Abstract][Full Text] [Related]
4. Oral bisphosphonates: A review of clinical use in patients with bone metastases.
Major PP; Lipton A; Berenson J; Hortobagyi G
Cancer; 2000 Jan; 88(1):6-14. PubMed ID: 10618600
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates for the relief of pain secondary to bone metastases.
Wong R; Wiffen PJ
Cochrane Database Syst Rev; 2002; 2002(2):CD002068. PubMed ID: 12076438
[TBL] [Abstract][Full Text] [Related]
6. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
Paterson AH; Kanis JA; Powles TJ; McCloskey E; Hanson J; Ashley S
Can J Oncol; 1995 Dec; 5 Suppl 1():54-7. PubMed ID: 8853526
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints.
Major PP; Cook R
Am J Clin Oncol; 2002 Dec; 25(6 Suppl 1):S10-8. PubMed ID: 12562046
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates for cancer patients: why, how, and when?
Body JJ; Mancini I
Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates for advanced prostate cancer.
Yuen KK; Shelley M; Sze WM; Wilt T; Mason MD
Cochrane Database Syst Rev; 2006 Oct; (4):CD006250. PubMed ID: 17054286
[TBL] [Abstract][Full Text] [Related]
10. Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.
Ibrahim A; Scher N; Williams G; Sridhara R; Li N; Chen G; Leighton J; Booth B; Gobburu JV; Rahman A; Hsieh Y; Wood R; Vause D; Pazdur R
Clin Cancer Res; 2003 Jul; 9(7):2394-9. PubMed ID: 12855610
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates to prevent skeletal complications in men with metastatic prostate cancer.
Smith MR
J Urol; 2003 Dec; 170(6 Pt 2):S55-7; discussion S57-8. PubMed ID: 14610411
[TBL] [Abstract][Full Text] [Related]
12. Should bisphosphonates be standard therapy for bone pain?
Paterson AH
Support Care Cancer; 1997 May; 5(3):200-4. PubMed ID: 9176965
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates in the prevention and treatment of bone metastases.
Ramaswamy B; Shapiro CL
Oncology (Williston Park); 2003 Sep; 17(9):1261-70; discussion 1270-2, 1277-8, 1280. PubMed ID: 14569853
[TBL] [Abstract][Full Text] [Related]
14. [The effect of bisphosphonates on pain relief in patients with bone metastases: A status article based on the Cochrane analysis: "Bisphosphonates for the relief of pain secondary to bone metastasis"].
Ejlertsen B; Kristensen B
Ugeskr Laeger; 2003 May; 165(20):2089-91. PubMed ID: 12812098
[No Abstract] [Full Text] [Related]
15. How can we improve the treatment of bone metastases further?
Coleman RE
Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S7-13. PubMed ID: 9801853
[TBL] [Abstract][Full Text] [Related]
16. Aredia: the once-monthly infusion for the treatment of bone metastases.
Lipton A
Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S1-5. PubMed ID: 9801852
[TBL] [Abstract][Full Text] [Related]
17. The use of bisphosphonates in patients with breast cancer.
Van Poznak CH
Cancer Control; 2002; 9(6):480-9. PubMed ID: 12514566
[TBL] [Abstract][Full Text] [Related]
18. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.
Berenson JR; Hillner BE; Kyle RA; Anderson K; Lipton A; Yee GC; Biermann JS;
J Clin Oncol; 2002 Sep; 20(17):3719-36. PubMed ID: 12202673
[TBL] [Abstract][Full Text] [Related]
19. The emerging role of bisphosphonates in prostate cancer.
Posadas EM; Dahut WL; Gulley J
Am J Ther; 2004; 11(1):60-73. PubMed ID: 14704597
[TBL] [Abstract][Full Text] [Related]
20. [Bisphosphonates in the therapy of cancer patients].
Jantunen E; Kumpulainen E
Duodecim; 1999; 115(1):27-32. PubMed ID: 11830857
[No Abstract] [Full Text] [Related]
[Next] [New Search]
